From: Observational long-term follow-up study of rapid food oral immunotherapy with omalizumab
Characteristics | LTFU participants |
---|---|
Number of ITT participants | 34 |
Sex, male (n), female (n) | M (23), F (11) |
Age at beginning of original phase I trial in years, median (range) | 8.7 (4.6–16.9) |
With other atopic conditions | |
Atopic dermatitis (%) | 57% |
Atopic rhinitis (%) | 73% |
Asthma (%) | 63% |
With number food(s) in OIT | |
1 food in OIT, n (%) | 6 (17.6%) |
2 foods in OIT, n (%) | 7 (20.6%) |
3 foods in OIT, n (%) | 5 (14.7%) |
4 foods in OIT, (n (%) | 9 (26.5%) |
5 foods in OIT, n (%) | 7 (20.6%) |
With food in OITa | |
Almond, n (%) | 6 (17.6%) |
Cashew, n (%) | 18 (52.9%) |
Egg, n (%) | 11 (32.4%) |
Hazelnut, n (%) | 7 (20.6%) |
Milk, n (%) | 10 (29.4%) |
Peanut, n (%) | 26 (76.5%) |
Pecan, n (%) | 8 (23.5%) |
Walnut, n (%) | 10 (29.4%) |